OncoNano Medicine, Inc.
4 clinical trials · Sponsor
◉ Watch OncoNano Medicine, Inc.
| Record | Firm | Date |
|---|---|---|
| A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. (NCT06022029) | OncoNano Medicine, Inc. | 2023-10-13 |
| A Study to Evaluate Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung Malignancies (NCT05048082) | OncoNano Medicine, Inc. | 2022-04-13 |
| A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri Mets (NCT04950166) | OncoNano Medicine, Inc. | 2021-11-30 |
| A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer (NCT03735680) | OncoNano Medicine, Inc. | 2019-08-09 |
Track OncoNano Medicine, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.